Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Lindsey

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
The Journal of Clinical Investigation|July 15, 2025
Integrative mapping of pre-existing influenza immune landscapes predicts vaccine responseStephanie Hao, Ivan Tomic, Benjamin B Lindsey, et al.
The Lancet. Respiratory Medicine|June 26, 2019
Effect of a Russian-backbone live-attenuated influenza vaccine with an updated pandemic H1N1 strain on shedding and immunogenicity among children in The Gambia: an open-label, observational, phase 4 studyBenjamin B Lindsey, Ya Jankey Jagne, Edwin P Armitage, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2025
Integrative Mapping of Pre-existing Immune Landscapes for Vaccine Response PredictionStephanie Hao, Ivan Tomic, Benjamin B Lindsey, et al.
The Lancet. Microbe|December 9, 2021
The effect of live attenuated influenza vaccine on pneumococcal colonisation densities among children aged 24-59 months in The Gambia: a phase 4, open label, randomised, controlled trialChikondi Peno, Edwin P Armitage, Melanie Clerc, et al.
Pathogens & Immunity|September 20, 2021
Generation of a Novel SARS-CoV-2 Sub-genomic RNA Due to the R203K/G204R Variant in Nucleocapsid: Homologous Recombination has Potential to Change SARS-CoV-2 at Both Protein and RNA LevelShay Leary, Silvana Gaudieri, Matthew D Parker, et al.
Biorxiv : the Preprint Server for Biology|April 21, 2021
Generation of a novel SARS-CoV-2 sub-genomic RNA due to the R203K/G204R variant in nucleocapsid: homologous recombination has potential to change SARS-CoV-2 at both protein and RNA levelShay Leary, Silvana Gaudieri, Matthew D Parker, et al.
Cell Reports. Medicine|January 14, 2022
Prior upregulation of interferon pathways in the nasopharynx impacts viral shedding following live attenuated influenza vaccine challenge in childrenAndré G Costa-Martins, Karim Mane, Benjamin B Lindsey, et al.
Iscience|November 3, 2021
The impact of viral mutations on recognition by SARS-CoV-2 specific T cellsThushan I de Silva, Guihai Liu, Benjamin B Lindsey, et al.
Cell Reports. Medicine|March 4, 2022
Erratum: Prior upregulation of interferon pathways in the nasopharynx impacts viral shedding following live attenuated influenza vaccine challenge in childrenAndré G Costa-Martins, Karim Mane, Benjamin B Lindsey, et al.
Medrxiv : the Preprint Server for Health Sciences|July 16, 2021
Risk factors for SARS-CoV-2 seroprevalence following the first pandemic wave in UK healthcare workers in a large NHS Foundation TrustDavid Hodgson, Hayley Colton, Hailey Hornsby, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
The Journal of Clinical Investigation|July 15, 2025
Integrative mapping of pre-existing influenza immune landscapes predicts vaccine responseStephanie Hao, Ivan Tomic, Benjamin B Lindsey, et al.
The Lancet. Respiratory Medicine|June 26, 2019
Effect of a Russian-backbone live-attenuated influenza vaccine with an updated pandemic H1N1 strain on shedding and immunogenicity among children in The Gambia: an open-label, observational, phase 4 studyBenjamin B Lindsey, Ya Jankey Jagne, Edwin P Armitage, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2025
Integrative Mapping of Pre-existing Immune Landscapes for Vaccine Response PredictionStephanie Hao, Ivan Tomic, Benjamin B Lindsey, et al.
The Lancet. Microbe|December 9, 2021
The effect of live attenuated influenza vaccine on pneumococcal colonisation densities among children aged 24-59 months in The Gambia: a phase 4, open label, randomised, controlled trialChikondi Peno, Edwin P Armitage, Melanie Clerc, et al.
Pathogens & Immunity|September 20, 2021
Generation of a Novel SARS-CoV-2 Sub-genomic RNA Due to the R203K/G204R Variant in Nucleocapsid: Homologous Recombination has Potential to Change SARS-CoV-2 at Both Protein and RNA LevelShay Leary, Silvana Gaudieri, Matthew D Parker, et al.
Biorxiv : the Preprint Server for Biology|April 21, 2021
Generation of a novel SARS-CoV-2 sub-genomic RNA due to the R203K/G204R variant in nucleocapsid: homologous recombination has potential to change SARS-CoV-2 at both protein and RNA levelShay Leary, Silvana Gaudieri, Matthew D Parker, et al.
Cell Reports. Medicine|January 14, 2022
Prior upregulation of interferon pathways in the nasopharynx impacts viral shedding following live attenuated influenza vaccine challenge in childrenAndré G Costa-Martins, Karim Mane, Benjamin B Lindsey, et al.
Iscience|November 3, 2021
The impact of viral mutations on recognition by SARS-CoV-2 specific T cellsThushan I de Silva, Guihai Liu, Benjamin B Lindsey, et al.
Cell Reports. Medicine|March 4, 2022
Erratum: Prior upregulation of interferon pathways in the nasopharynx impacts viral shedding following live attenuated influenza vaccine challenge in childrenAndré G Costa-Martins, Karim Mane, Benjamin B Lindsey, et al.
Medrxiv : the Preprint Server for Health Sciences|July 16, 2021
Risk factors for SARS-CoV-2 seroprevalence following the first pandemic wave in UK healthcare workers in a large NHS Foundation TrustDavid Hodgson, Hayley Colton, Hailey Hornsby, et al.
Pageof 8